50) ower in diabetic rats than in the control group. |
51) icipants to either the OPTIMAL or control group. |
52) no such difference was observed in the KD group. |
53) h as identified by the expert-based focus group. |
54) ically using a framework of fears and age group. |
55) 1), respectively, in the ICU than non-ICU group. |
56) findings; and will include a consultative group. |
57) h was included into superantigen negative group. |
58) ell function (β) compared to the control group. |
59) particularly for those in the rickettsial group. |
60) trength or vertical jump height in either group. |
61) f the season for the CT, but not control, group. |
62) to poorer psychological health among this group. |
63) red to sharpen treatment concepts in this group. |
64) , it is important to focus solely on this group. |
65) o-female (sex) ratios in mortality by age group. |
66) ommunicate within a spatially distributed group. |
67) f, exercising in fitness centres for each group. |
68) ccurrence worldwide in the paediatric age group. |
69) divided into two groups: a CT and Control group. |
70) Usually that is the control group. |
71) standards of physical health in this age group. |
72) , p = 0.0412) compared to those in the AA group. |
73) research approaches used to describe this group. |
74) healthcare is delivered for this patient group. |
75) en compared to XBL, but only in the serum group. |
76) in the animals assigned to ENAP treatment-group. |
77) nhanced Recovery of Liver Transplantation Group of Enhanced Recovery after Surgery C |
78) Results: In this group of 9 patients, the flap harvesting t |
79) OXA-48 is a member of a group of CHDLs named OXA-48-like enzymes. |
80) A working group of CML experts from LA discussed 22 |
81) The writing group of Expert consensus on the applicati |
82) Ser, Tyr, or Cys activates the sulfhydryl group of GSH. |
|